C12N 2750/10041
Use of virus, viral particle or viral elements as a vector
C12N2750/10041 (Use of virus, viral particle or viral elements as a vector) appears on 27 US grants and 30 published applications in this corpus.
Search patents in C12N- Granted patents
- 27
- Published applications
- 30
- Assignees
- 18
- Inventors
- 55
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 4 |
| 2003 | 2 | 2 |
| 2004 | 1 | 2 |
| 2005 | 0 | 1 |
| 2006 | 2 | 4 |
| 2007 | 2 | 3 |
| 2008 | 1 | 0 |
| 2009 | 2 | 1 |
| 2010 | 4 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 2 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 1 | 4 |
| 2024 | 1 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2750/10043Viral genome or elements thereof as genetic vectorIndexing code24
- C12N 2750/10042Virus or viral particle as vehicleIndexing code0
- C12N 2750/10044Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code0
- C12N 2750/10045Special targeting system for viral vectorsIndexing code0
Recent patents
- Prostate targeting adeno-associated virus serotype vectors26 May 2026US 12,636,382 B2University of Massachusetts
- Apparatus for efficient genetic modification of cells12 Nov 2024US 12,139,697 B2The Charles Stark Draper Laboratory, Inc.
- Apparatus for efficient genetic modification of cells21 Feb 2023US 11,584,908 B2The Charles Stark Draper Laboratory, Inc.
- Prostate-targeting adeno-associated virus serotype vectors30 Aug 2022US 11,426,469 B2University of Massachusetts
- Synthetic capsid proteins and uses thereof24 Jan 2017US 9,550,812 B2Ceva Sante Animale
- Self-replicating dna expression system and immunogen17 Oct 2024US 2024/0344100 A1
- Methods and compositions for the treatment of neurologic disease19 Oct 2023US 2023/0330195 A1Regents of the University of Minnesota
- Apparatus for efficient genetic modification of cells16 Mar 2023US 2023/0080444 A1The Charles Stark Draper Laboratory, Inc.
- Prostate targeting adeno-associated virus serotype vectors9 Mar 2023US 2023/0073187 A1University of Massachusetts
- Apparatus for efficient genetic modification of cells2 Mar 2023US 2023/0063282 A1The Charles Stark Draper Laboratory, Inc.
Most cited
By later US patents
- Porcine circoviruses vaccines diagnostic reagents105US 6,391,314 B1Merial Limited · 2002
- Porcine circovirus vaccine and diagnostics reagents99US 6,368,601 B1Merial Limited · 2002
- Porcine circoviruses, vaccines and diagnostic reagents77US 6,660,272 B2Merial Limited · 2003
- Methods to culture circovirus65US 6,794,163 B2University of Saskatchewan · 2004
- Porcine circoviruses, vaccines and diagnostic reagents58US 7,122,192 B2Merial Limited · 2006